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Abstract
Background: Proliferation of terms describing the science of effectively promoting and supporting the use of research
evidence in healthcare policy and practice has hampered understanding and development of the field. To address this,
an international Terminology Working Group developed and published a simplified framework of interventions to
promote and integrate evidence into health practices, systems, and policies. This paper presents results of validation
work and a second international workgroup meeting, culminating in the updated AIMD framework [Aims, Ingredients,
Mechanism, Delivery].
Methods: Framework validity was evaluated against terminology schemas (n = 51); primary studies (n = 37); and
reporting guidelines (n = 10). Framework components were independently categorized as fully represented, partly
represented, or absent by two researchers. Opportunities to refine the framework were systematically recorded.
A meeting of the expanded international Terminology Working Group updated the framework by reviewing and
deliberating upon validation findings and refinement proposals.
Results: There was variation in representativeness of the components across the three types of literature, in particular for
the component ‘causal mechanisms’. Analysis of primary studies revealed that representativeness of this concept lowered
from 92 to 68% if only explicit, rather than explicit and non-explicit references to causal mechanisms were included.
All components were very well represented in reporting guidelines, however the level of description of these was lower
than in other types of literature. Twelve opportunities were identified to improve the framework, 9 of which were
operationalized at the meeting. The updated AIMD framework comprises four components: (1) Aims: what do you want
your intervention to achieve and for whom? (2) Ingredients: what comprises the intervention? (3) Mechanisms: how do
you propose the intervention will work? and (4) Delivery: how will you deliver the intervention?
Conclusions: The draft simplified framework was validated with reference to a wide range of relevant literature
and improvements have enhanced useability. The AIMD framework could aid in the promotion of evidence into
practice, remove barriers to understanding how interventions work, enhance communication of interventions and
support knowledge synthesis. Future work needs to focus on developing and testing resources and educational
initiatives to optimize use of the AIMD framework in collaboration with relevant end-user groups.
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Background
Understanding and describing the science of effectively
promoting and sustaining the use of research evidence
in healthcare policy and practice is important to access
literature; develop interventions; and plan, report, and
review research. However, there are numerous terms to
describe and conceptualise this science – for example
Quality Improvement (QI), Implementation Science and
Knowledge Translation. Compounding this, there are
myriad theories and frameworks designed to guide the
conceptualisation and development of interventions to
promote evidence uptake into health practices, systems
and policies [1–3]. Guidance on how to use these is
lacking, evidence on the benefits of their use is sparse,
and they themselves compound terminology issues by
proposing an array of inconsistent terms for similar con-
cepts. It is therefore unsurprising that theories and
frameworks are only used to develop interventions about
10% of the time [4].
The existence of multiple terminologies and frame-
works hampers advancement of this field [5, 6]. One of
numerous examples is searching for literature; when
McKibbon et al. developed search filters to identify
literature on actions and processes of getting research
findings used in practice, all of the filters had poor speci-
ficity (approximately 50–60%). This was because use of
multiple terms resulted in large search yields containing
many irrelevant articles [7].
To address this issue, an international collaboration of
scholars – the Terminology Working Group - convened
in September 2012 in Ottawa, Canada, to develop a sim-
plified framework to describe interventions to promote
and integrate evidence into health practices, systems,
and policies. Whilst it appears counter-intuitive to ad-
dress the problem of multiple frameworks with another
framework, a key aim of the project was not to supplant
existing models representing the full spectrum of ac-
tivities in this field, but to create an overarching
‘meta-framework’ that accommodates the use of existing
frameworks which are often designed for a more specific
purpose. The framework was deliberately ‘terminology ag-
nostic’ for two reasons – first, to prevent exacerbating the
terminology issue; and second, to promote inter-sectoral
collaboration across the diversely named but related fields
that share the aim of improving healthcare quality. This
ambition was reflected by the research group, which
comprised members with diverse research foci including
quality improvement, evidence synthesis, policy, informa-
tion science, public health, patient safety and behaviour
change. The group chose to focus on interventions be-
cause we considered that this contributes substantially to
the terminology issue.
The resulting intervention framework comprised four
components:
1. Intended targets: The intended effects of
the intervention and/or its beneficiaries
(e.g., behavioural changes, policy changes,
technological changes);
2. Active ingredients: The critical components that
define the intervention and are required to initiate
change (e.g., educational workshop, opinion leader);
3. Causal mechanisms: The pathways or processes by
which it is proposed that an intervention effects
change or which change comes into effect. As with
ingredients, other taxonomies could be used in
conjunction with AIMD to add detail. The proposed
mechanism could be based on either theory or
empirical evidence (e.g. “the educational workshop
is designed to address knowledge gaps and by
providing new knowledge, influence practice”;
“use of an opinion leader was successful in
influencing the beliefs and attitudes of clinicians
regarding the importance of hand hygiene”)
4. Mode of delivery or application: The ways in which
active ingredients are applied (e.g., face-to-face, on-
line, written material,).
This intervention framework, hereafter referred to as
‘simplified framework version 1,’ was published explicitly
as a draft requiring further iteration [5]. This paper out-
lines results of a validation project and a subsequent sec-
ond international meeting, and presents the updated
intervention framework (simplified framework version
2), hereafter referred to as the AIMD framework [Aims,
Ingredients, Mechanism, Delivery].
Methods
Validation project
Our operational definition of ‘framework validity’ was
drawn from a study examining various methods in which
multifaceted quality frameworks were validated:
“a process by which a judgement is made as to
whether a tool is fit for purpose… the structure of
a framework and the way in which it is validated
should take into account the purpose for which the
framework is to be used” (Inglis 2008 p. 350) [8].
This definition is distinguished from validity as (typically)
applied to establishing the scope and the underlying con-
structs of measurement instruments [9]. The validation
project addressed four research questions developed based
upon the above definition:
1. Does the simplified framework represent the
domains described within existing terminology
schemas?
Bragge et al. BMC Medical Research Methodology  (2017) 17:38 Page 2 of 11
This validation question was designed to test whether
our tool could be used as a common framework across
diverse change literatures. simplified framework version
1 was validated against 51 terminology schemas identi-
fied in a systematic scoping review [10]. Examples of
such schemas include the Consolidated Framework for
Implementation Research (CFIR) [11] and the taxonomy
of methods for implementing change in practice [12].
Two researchers [CL, JB or HC] independently adjudged
representativeness of each component of the framework
in each of the 51 terminology schemas.
2. Is the simplified framework represented in published
primary studies?
This validation question aimed to evaluate whether
relevant published research was already reporting the
four domains identified in simplified framework version
1. Two researchers [LA, SDS] independently adjudged
representativeness of the framework in 37 primary
studies, sourced from four Cochrane [13–16] and six
non-Cochrane systematic reviews [17–22] identified by
the working group. These reviews were purposively
sampled to encompass five sectors pertinent to promoting
and supporting the use of research evidence in healthcare
policy and practice: health behaviour change, patient
safety, policy, public health, and quality improvement
(two reviews per sector). Individual studies within each
systematic review were also purposively sampled from
to encompass different study designs and setting. The
37 identified primary studies pertained to health behaviour
change (n = 8), patient safety (n = 5), policy (n = 8), public
health (n = 8), and quality improvement (n = 8) and in-
cluded 18 randomised controlled trials (RCTs), 5 before-
after studies, 4 cohort studies, 4 interrupted time series
studies, 3 cross-sectional studies, 2 controlled clinical trials,
and an observational study.
Consideration of both explicit and non-explicit references
to ‘causal mechanisms’ was incorporated into analysis. An
‘explicit’ reference to a causal mechanism details how the
intervention is proposed to alter healthcare practice, for
example: “we postulated that provision of an education pro-
gram would address identified gaps in knowledge amongst
medical practitioners.” A ‘non-explicit’ reference describes
the intervention, but the mechanism of action needs to be
inferred by the reader, for example: “we provided an educa-
tion program to medical practitioners.”
3. Is the simplified framework represented in major
reporting guidelines for interventions?
This validation question aimed to evaluate whether rele-
vant reporting guidelines recommended that intervention
description encompass our four domains. We defined a
relevant reporting guideline as one which was specific
to reporting on complex interventions/interventions ef-
fectively promoting and sustaining the use of research
evidence in healthcare policy and practice. All 280
reporting guidelines within the EQUATOR (Enhancing
the QUAlity and Transparency Of health Research)
Network online library (as at July 28, 2015) [23] were
screened to identify relevant reporting guidelines. Two
researchers [PB, AD] independently adjudged represen-
tativeness of the framework in the ten reporting guide-
lines identified following screening:
 Assessment of transferability and adaptation of
health promotion interventions (ASTAIRE), [24];
 Consolidated Standards of Reporting Trials
(CONSORT) Cluster Extension, [25];
 CONSORT Non Pharmacological Therapies
(NPT) extension, [26];
 CONSORT Pragmatic Trials extension, [27];
 Criteria for Reporting the Development and
Evaluation of Complex Interventions (CReDECI) 2,
[28, 29];
 Reporting standards for studies of tailored
interventions, [30];
 Template for intervention description and
replication (TIDieR), [31];
 Transparent Reporting of Evaluations with
Nonrandomized Designs (TREND), [32];
 Standards for QUality Improvement Reporting
Excellence (SQUIRE) [33]; and
 Workgroup for Intervention Development and
Evaluation Research (WIDER) [34].
For all three validation questions:
 Two researchers independently evaluated the
representativeness of each component of the
framework in the literature, where ‘fully’
represented was defined as the original framework
component being represented in full; ‘partly’
was defined as the component being partially
represented, but with some details unclear or
missing; and ‘absent’ as no aspect of the
component being referred to;
 Standardised data extraction forms were
developed and piloted; and
 The weighted Cohen’s kappa statistic was used
as a measure of categorical agreement between
the two researchers [35]. Kappa calculations
were performed in Microsoft Excel® using a
linear weighting model where the weight of
disagreement of Absent × Fully Represented
was twice the weights of the other
disagreements.
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In examining framework representation across diverse
research literature (questions 1–3), we postulated that
more representativeness would equate to better frame-
work validity, based upon the above definition.
Question four focused on how our validation work
from questions 1–3 could refine simplified framework
version 1:
4. How can the useability of simplified framework
version 1 be improved? This validation question
was designed to capture overarching information
from the above three questions, for example
whether there was any suggestion of missing
domains or how clarity and/or language could
be improved. Our intent was to use the answers
to this question to guide framework refinements.
We documented opportunities to potentially
improve framework useability during the three
validation studies. Opportunities to improve
the framework were noted by members of the
research team, either in separate word document
files or in fields built into the data extraction form.
Figure 1 summarises the methodological approach.
2nd International meeting
The Terminology Working Group that convened in
September 2012 to develop simplified framework version
1 grew to 27 members as a result of the validation pro-
ject. Twenty members of the group attended a 2-day
working meeting in February 2015 in Ottawa, Canada.
A full list of Terminology Working Group members
involved in the project and their affiliations can be
found in Additional file 1. The primary aim of this
meeting was to refine the framework based upon the
validation project. Meeting activities included a presen-
tation on the background and the development of the
original framework [5]; an overview of a scoping review
conducted by members of the group on similar frame-
works, i.e. classifications that describe interventions for
the promotion of integration of evidence into practice,
[10]; and presentation of results of the validation pro-
ject, including potential refinements identified. A series
of breakout and whole group discussions were facili-
tated by the meeting convenors (HC, JG, PB) to address
two questions:
1. Are the four existing framework components
fundamentally important and critical?
2. How do we best present and define the four
elements to optimize comprehension?
Results
Validation project
Table 1 presents results pertaining to validation ques-
tions 1–3. Specifically, it presents the percentage of arti-
cles with each element represented across all included
articles in each of the three types of literature for which
framework validation was undertaken.
Question 1. Does simplified framework version 1 repre-
sent the domains described within existing terminology
schemas? At least one component of simplified frame-
work version 1 was represented in 48 of the 51 ter-
minology schemas. Representation rates ranged from
Fig. 1 Summary of approaches to validation questions
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59% (causal mechanisms) to 96% (active ingredients).
The range of full representation was 57–88% and the
range of part representation was 2 to 14%.
Question 2. Is simplified framework version 1 represented
in published primary studies?
At least one component of simplified framework ver-
sion 1 was represented in all 37 primary studies. Repre-
sentation rates ranged from 81% (active ingredients) to
100% (intended targets). The range of full representation
was 60–100% and the range of part representation was 0
to 22%. In contrast to its representation in terminology
schemas, causal mechanisms (92%) was highly repre-
sented in the primary studies. However, this included
non-explicit causal mechanisms, identified with reference
to the Behaviour Change Wheel [36]. A separate analysis
based on only identifying explicit causal mechanisms re-
sulted in a lower representation of causal mechanisms of
68% (comprising 41% full representation, 27% part repre-
sentation and 32% non-representation).
Question 3. Is simplified framework version 1 represented
in major reporting guidelines? At least one component of
simplified framework version 1 was represented in all 10
reporting guidelines. Representation rates ranged from
95% (active ingredients, mode of delivery/application
and intended targets) to 100% (causal mechanisms). The
range of full representation was 45–65% and the range
of part representation was 35 to 50%.
Weighted kappa scores for agreement between the
two independent validation ratings represented a fair
(0.364, reporting guidelines) to substantial (0.725, pri-
mary studies) strength of agreement.
Question 4. How can the useability of simplified frame-
work version 1 be improved?
Twelve opportunities to refine the framework were
identified, comprising four pertaining to the overall
framework and two each pertaining to each of the four
components. The four overall refinements gave import-
ant insights into the framework and how it could be
used. For example, in the case of multifaceted interven-
tions, while each facet may be considered an individual
and equally important active ingredient, there may be
various causal mechanisms, modes of delivery, and/or
targets across the facets.
The eight opportunities pertaining specifically to the
four components of version 1 revealed a need for con-
ceptual clarity and more precise definition. For example,
active ingredient appeared to overlap with causal mecha-
nisms because knowledge of why an ingredient is active
can be associated with knowledge of how an interven-
tion is thought to work – for example, education could
be considered both the active ingredient and causal
mechanism in an education program. Relatedly, defini-
tional issues were identified - for example, combining
mode of delivery with application hindered the validation
study, and furthermore, mode of delivery was thought to
be only one of several factors that determine the replic-
ability of an intervention.
2nd International meeting
Following deliberation across our diverse group, 9 of the 12
proposed refinements to simplified framework version 1
from question 4 were incorporated into AIMD; one of
Table 1 Results from validation of the simplified framework by question (%)
Validation question [n publications] Active ingredients Causal mechanisms Mode of delivery or application Intended targets
Q1. Does simplified framework version 1
represent the domains described within
existing terminology schemas?
Represented 96 59 73 80
Fully 88 57 59 78
Partly 8 2 14 2
Absent 4 41 27 20
Kappa 0.475: moderate strength of agreementa
Q2. Is simplified framework version 1
represented in published primary studies?
Represented 81 92b 82 100
Fully 70 92 59 100
Partly 11 0 22 0
Absent 19 8 19 0
Kappa 0.725: substantial strength of agreementb
Q3. Is simplified framework version 1
represented in major reporting guidelines?
Represented 95 100 95 95
Fully 60 65 50 45
Partly 35 35 45 50
Absent 5 0 5 5
Kappa 0.364: fair strength of agreementa
aInterpretation of strength of agreement based upon Landis and Koch [35]
bKappa based upon agreement when judgement of representativeness of causal mechanisms included both ‘explicit’ and ‘non-explicit causal mechanisms
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the four proposed overall framework refinements and
all 8 opportunities pertaining specifically to the four
components of version 1. In addition to considering the
validation work conducted prior to the meeting, two
other key concepts were also considered: 1) the original
language for the descriptions of the framework compo-
nents was difficult to apply, and 2) the framework had
to remain congruent with other frameworks of imple-
mentation interventions for it to be applicable across
disciplines and sectors. Table 2 presents a detailed de-
scription of refinements proposed through the valid-
ation and made in the meeting.
The AIMD framework
Table 3 presents the validated and revised version of the
simplified framework version 1 - the AIMD framework.
The AIMD framework retains the four components
of its predecessor [5], yet includes simpler and clearer
concepts and associated descriptions. For instance,
‘Intended Targets’ has been changed to ‘Aims’ to clarify
that the component reflects what will be achieved and
for whom; ‘Active’ has been removed from ‘Active in-
gredients’ to differentiate this component from the
mechanism. Component descriptions were also simpli-
fied into short direct questions, as this was perceived
in the meeting to be an easier way for end-users to
engage with the concepts.
Given the pivotal importance of context in implemen-
tation science, there was considerable debate on whether
(and how) to accommodate contextual factors that can
shape the integration of research evidence into practice
and policy. Recognizing their aim to address one aspect
of implementation science, group members decided to:
deem the framework as one element within the larger
process of changing practice; maintain a focus on inter-
vention characteristics, rather than the contextual factors
that may or may not shape the intervention. Further-
more, although the importance of context is well-
recognized [11], current understandings of this concept
remain imperfect and incomplete. It was therefore de-
cided to retain the four components in simplified
framework version 1, rather than add a component per-
taining to context. Future development of the AIMD
framework could potentially elucidate the relationship
between intervention and context.
Discussion
Through a validation project and international meeting,
we have updated a simplified framework of interven-
tions to promote and integrate evidence into health
practices, systems, and policies. Referred to as AIMD,
the framework comprises four components: (1)Aims:
what do you want your intervention to achieve and for
whom?; (2)Ingredients: what comprises the intervention?;
(3)Mechanisms: how do you propose the intervention
will work?; and (4)Delivery: how will you deliver the
intervention?
The validation process reported in this paper has
several key strengths. First, it synthesised extensive input
from the international research community with a broad
range and large volume of literature, including literature
sourced from systematic reviews. This is consistent with
published framework validation strategies [8]. Second, in
addition to evaluating the representativeness of the frame-
work in relevant literature, it also involved gathering op-
portunities to improve the usefulness of the framework
from the same literature. Third, all validation was inde-
pendently completed by two independent researchers,
with weighted kappa scores demonstrating a fair to sub-
stantial level of inter-rater agreement.
Despite these strengths, some methodological limita-
tions warrant mention. First, the definitions of, ‘fully repre-
sented, ‘partly represented’, and ‘absent’ were established
iteratively, rather than determined a priori. Notwith-
standing this, the resulting definitions were similar
across the three teams. Furthermore, through pilot test-
ing and discussion, the definitions used to validate the
framework were consistently applied within each team.
Secondly, we acknowledge that the framework was
evaluated predominantly by its developers. However,
three of the 11 study authors (SS, DM, AD) were not
involved in the initial framework development. Finally,
it was not possible to map the framework to several
reporting guidelines under development at time of study:
the REporting Manualised INterventions for Dissemin-
ation and Evaluation (REMINDE) statement; CONSORT
Extension for Social and Psychological Interventions:
CONSORT-SPI; Consort extension to stepped wedge clus-
ter randomised controlled trial; Guideline for reporting
evidence based practice educational interventions and
teaching (GREET) statement; Adapting TIDieR checklist
for reporting public health, health systems and social
and environmental policy interventions (UNTIDieR);
Developing Standards for Reporting Phase IV Imple-
mentation studies (StaRI); and Reporting guidelines for
implementation research and operational research [37].
As such, the strength of simplified framework version 1
with reference to these reporting guidelines is yet to be
determined.
The representativeness of the simplified framework
version 1 components varied across the three types of
literature, reflecting the different questions being ad-
dressed through each of the validation exercises. Most
notably, all components achieved at least 95% represen-
tation in the reporting guidelines. This is understandable
given that guidelines are by nature a more comprehen-
sive coverage of core concepts than primary studies.
There was also considerable difference in the range of
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Table 2 Summary of evolution of simplified framework version 1 to the AIMD framework (simplified framework version 2)
Version 1 to updated version 2 components Potential refinements identified Refinements made: 2nd International meeting
Intended Targets to AIMS Conceptually overlaps with causal
mechanisms via reference to
intended effects
Renamed as ‘Aims’ in version 2
and redefined to reflect that the
intended effects are the aims of the
intervention and the beneficiaries
are who the aims are directed towards
Evaluation could be considered part of
intended target in that it quantifies the
expected change; therefore intended target
could be redefined to consider aim of study
See above
Active Ingredients to INGREDIENTS Conceptually overlaps with causal
mechanism (e.g., an active ingredient
such as ‘persuasion’ implies a causal
mechanism)
The word active was removed from
version 1 to avoid confusion between
the intervention ingredients and the
mechanism by which the intervention
works. This resulted in ‘Ingredients’ in
version 2
Best defined as ‘what it is’ (i.e., remove
bulleted points, 3 and 4) or ‘as empirically
established’
The single term ‘Ingredients’ acts as
a prompt to provide details
(i.e., the component parts) rather than a
broad nominal description
Causal Mechanisms to MECHANISM Conceptually overlaps with active
ingredients as exemplified above
As above
The term could refer to ‘how it is known
to work’ (empirically established) or ‘how it
is thought to work’ (theoretical rationale) –
the definition could be refined or the
concept of ‘rationale’ could be incorporated
differently?
‘Causal’ was felt to indicate an
empirically established mechanism,
rather than a hypothesized mechanism.
Therefore, ‘causal’ was removed from
version 1 to allow for consideration of
theoretical or empirical rationale. This
resulted in ‘Mechanism’ in version 2
Mode of Delivery or Application to DELIVERY Conceptually overlaps with active ingredient
(e.g., local opinion leader implies active
ingredient, i.e., a local opinion leader can
deliver an intervention, but a local opinion
leader is also an active ingredient, and
could be delivered in multiple modes of
delivery such as phone, face-to-face)
There can be more to delivery than just
mode. Therefore, this component was
renamed as ‘Delivery’ in version 2, and
redefined to encompass information
such as mode, content and dosage
Mode of delivery alone is insufficient for
replicability. Furthermore, combining mode
of delivery with application is problematic
as one may or may not be covered; this
category may need to be redefined to
include other vital information
(e.g., eligibility criteria, mode, delivery
personnel, content, dosage (i.e., duration,
intensity), audience and its size of audience,
number of care providers and centres,
intervention fidelity and its measurement,
the identification of breaches and how the
intervention was modified, context,
standardisation and tailoring strategies,
clustering, blinding, enrolment, and
allocation
Per above, ‘Delivery’ now defined more
broadly to improve applicability to
non-clinical settings
(e.g., public health, policy)
Across all framework components Consider how post-intervention information
with potential application to future
interventions could be used (e.g., fidelity,
what was learned about causal mechanisms,
contexts in which intervention may or may
not be effective, financial considerations
such as cost-benefit, etc.). This information
could be considered as part of the
description of a published study
intervention or it could be assumed that
this information is fed into future
intervention studies (i.e., methods description)
The framework exists within the limits of
the intervention itself; it does not extend
to other contextual concepts
(e.g. fidelity, rationale). Therefore, no
refinements to version 1 were made
pertaining to this issue
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representation values in the reporting guidelines com-
pared to the terminology schemas and primary studies.
The most substantial variation between the three vali-
dation studies at the level individual framework compo-
nents was for causal mechanisms, which varied from
59% representation in terminology schemas to 100% in
reporting guidelines. However, the validation findings for
primary studies’ reporting of causal mechanisms (92%
representation) should be interpreted in the context that
non-explicit references to causal mechanisms, identified
with reference to the Behaviour Change Wheel, [36]
were included as ‘represented.’ According to a separate
analysis, restricting the definition of ‘represented’ to
explicit references to causal mechanisms substantially
lowered the representativeness rate to 68%. This raises
the question of how explicit reporting of causal mecha-
nisms needs to be. One answer is that the detail required
is that which maximises the replicability of a primary
study. Non-explicit descriptions of causal mechanisms
require these to be inferred by the reader, and this is
therefore subject to individual reader knowledge and in-
terpretation. For these reasons, we strongly advocate for
explicit, rather than non-explicit descriptions of proposed
causal mechanisms of interventions to promote uptake of
evidence into policy. The much lower figure derived when
limiting interpretation of reporting to explicit causal
mechanisms indicates that this is an important area of
future focus for the reporting of such interventions.
Overall, the variations in representativeness across the
three types of literature indicate specific areas in which
Table 3 The AIMD Framework
Component Description Definition and considerations
Aims What do you want your intervention to achieve
and for whom?
This component relates to the objective and outcome
of the intervention. Based on your endpoint, what are
you measuring in whom?
It could include consideration of proximal and
intermediate outcomes, and process outcomes
related to implementation.
Ingredients What comprises the intervention? These are the observable, replicable, and irreducible
aspects of the intervention. To increase the detail
specified, other taxonomies could be used in
conjunction with the AIMD framework. This might
include intervention taxonomies [38, 39] or reporting
guidance [31].
Mechanism How do you propose the intervention will work? This refers to the pathways or processes by which it
is proposed that an intervention effects change or which
change comes into effect. As with ingredients, other
taxonomies could be used in conjunction with AIMD to
add detail. The proposed mechanism could be based on
either theory or empirical evidence, and be made specific
to the setting. The use of mechanism may change
depending on if the framework is used for reporting or
designing: why was the ingredient selected (design) and
what is the pathway in which it worked (reporting).
Delivery How will you deliver the intervention? This encompasses logistical and practical information
pertaining to intervention delivery, including mode
(e.g. video, brochure); level (e.g. individual, team, population);
dose, frequency, intensity; who’s delivering; and size of target group.
Table 2 Summary of evolution of simplified framework version 1 to the AIMD framework (simplified framework version 2)
(Continued)
Further guidance is needed on how
to handle situations where there is more
than one intervention (i.e., is the tool used
per intervention or can a group of
interventions be scored together?)
Multiple intervention components
could be considered within AIMD.
No refinements to version 1 were made
pertaining to this issue
‘Rationale’ for the intervention could be
more explicitly covered, perhaps as a
stand-alone component by the components
and/or as a separate component
Not discussed at length in meeting.
Changes were made to version 1 to more
explicitly define ‘rationale’ within
‘Mechanism’ (see below)
The control condition should be described
in the same terms as the intervention
and/or the control condition justified
Not discussed at length in meeting. No
refinements to version 1 were made
pertaining to this issue
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AIMD can contribute to addressing the terminology
challenge. For example, the low representation of causal
mechanisms (59%) in existing frameworks suggests that
this aspect of intervention rationale is not well eluci-
dated despite the existence of over 50 terminology sche-
mas. The relatively low rate of ‘full’ representation of the
components in reporting guidelines indicates that although
the four components of the simplified model are present in
this literature, there is scope to describe these with more
granularity.
We anticipate several applications of the AIMD frame-
work. AIMD can serve as a framework for more effectively
communicating with each other about implementation
interventions. Indeed, this benefit was realized at our
meeting. Once we achieved consensus on terms and defi-
nitions, we were able to deploy these terms in rich discus-
sions about interventions across multiple disciplines. This
was because the group, having collaboratively developed
and explicitly defined the four AIMD components, had a
shared, unambiguous understanding of these elements of
interventions. In explicitly defining its four components,
the AIMD framework can also be used to guide the
development of intervention design and reporting
toolkits. If the term ‘AIMD’ and its associated elements
were to become universally accepted terms and defini-
tions for reporting, this could improve bibliographic
searching for intervention studies over time by providing
identifiers for more relevant citations and reducing the
need for multiple synonyms, therefore reducing the ‘noise’
of irrelevant citations.
Potential users of this framework include patient safety
agencies, clinicians, clinical quality improvement leads
(who are not necessarily researchers), journal editors,
implementation researchers, policy makers, patients,
reporting guidance developers, funders, and those in
public health. Dissemination practitioners and know-
ledge brokers could use the framework as a tool for
planning, evaluating, and adapting knowledge dissemin-
ation materials. Future additional research on AIMD is
required to establish how the AIMD framework can be
used by the above stakeholder groups. Such research
could address questions including:
 ‘Do the four components of AIMD inform and
facilitate implementation, quality improvement,
policy, patient safety?
 Does the framework promote comparisons between
studies, elucidate issues of intervention fidelity,
and further terminology within multi-faceted
interventions?
 Can it stimulate knowledge discovery?
 To what extent can AIMD facilitate educational
initiatives aimed at non-implementation
audiences?’
A key future priority is to make AIMD useable to end-
users, especially those involved in developing interventions
to promote evidence-informed healthcare practice and
policy. The true value of AIMD as a ‘meta-framework’ can
only be realised when it is linked to existing, more specific
intervention frameworks, worked examples and other re-
sources that can aid intervention developers in addressing
the four questions comprising the AIMD framework. The
effectiveness of AIMD in optimising intervention design
and reporting, as well as its impact on knowledge and ap-
plication of theory, can then be evaluated.
Conclusions
This study undertook a series of validation exercises of a
simplified framework of interventions promoting and
sustaining the use of research evidence in healthcare
policy and practice. Using a definition of validity specific
to frameworks – ‘whether a tool is fit for purpose’ – we
validated the original framework’s four components
(active ingredients, causal mechanisms, mode of deliv-
ery or application and intended targets) against termin-
ology schemas, primary studies, and reporting
guidelines. The results of the validation work, in
addition to opportunities to improve the framework
gathered through the validation activities, were used at
an international and multi-sectoral meeting to refine the
original simplified framework. The refined framework,
AIMD, represents core components of implementation
science interventions that are key to understanding an
intervention, which will contribute to better understand-
ing, design, evaluation, reporting, and communication in
this field.
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